# Liquid Biopsy for Early Non-small Lung Cancer Detection

> **NCT05462795** · — · COMPLETED · sponsor: **University of Arizona** · enrollment: 171 (actual)

## Conditions studied

- Non Small-cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Liquid biopsy for aberrant DNA methylation analysis - Indeterminate pulmonary nodule
- **DIAGNOSTIC_TEST:** Liquid biopsy for aberrant DNA methylation analysis - Known lung cancer for surgical resection
- **DIAGNOSTIC_TEST:** Liquid biopsy for aberrant DNA methylation analysis - Healthy volunteer
- **DIAGNOSTIC_TEST:** Liquid biopsy for aberrant DNA methylation analysis - Benign lung disease

## Key facts

- **NCT ID:** NCT05462795
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-02
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-03-22
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05462795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05462795, "Liquid Biopsy for Early Non-small Lung Cancer Detection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05462795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*